ESC 365 - Impact of established cardiovascular disease on outcomes in the Global Leaders trial

ESC Premium Access

Impact of established cardiovascular disease on outcomes in the Global Leaders trial

Session: Coronary artery disease - Epidermiology, prognosis and outcome

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor S. Garg (Blackburn, GB)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Scot Garg

Royal Blackburn Hospital, Blackburn (United Kingdom of Great Britain & Northern Ireland)

0 follower

7 more presentations in this session

Recurrent coronary heart disease in the year following myocardial infarction among US men and women between 2008 and 2015

Speaker: Doctor S. Peters (Utrecht, NL)

Management and outcomes of patients with unstable angina with undetectable, normal, or intermediate hsTnT levels - A RAPID CPU substudy

Speaker: Doctor M. Biener (Heidelberg, DE)

Percutaneous coronary intervention provided better result than optimal medical therapy in patients with chronic total occlusion: a metanalysis

Speaker: Doctor D. Khanra (CHESTER, GB)

Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study

Speaker: Doctor T. Unoki (Kumamoto, JP)

Coronary artery calcification predicts MACE and all-cause mortality in individuals undergoing non-cardiac computed tomography for non-cardiovascular indications

Speaker: Doctor D. Banerji (Boston, US)

Access the full session

Coronary artery disease - Epidermiology, prognosis and outcome

Speakers: Doctor S. Garg, Doctor S. Peters, Doctor M. Biener, Doctor D. Khanra, Doctor T. Unoki...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources